Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments ...

If shown to have broad spectrum antiviral activity, NV-387 could be used in a similar manner to how antibiotics are prescribed prior to identification of the pathogenic bacteria when patients ...

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / February 19, 2025 / NanoViricides, Inc. (NYSE ...

Expert Systems announced a significant milestone in a development of Traws Pharma’s (TRAW) H5N1 antiviral program ... demonstrating broad-spectrum efficacy against various flu strains, including ...